A framework to develop adapted treatment regimens to manage pediatric cancer in low‐ and middle‐income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP)
Scott C. Howard(Hospital Sant Joan de Déu Barcelona), Monika L. Metzger(St. Jude Children's Research Hospital), Ramandeep Singh Arora(Max Super Speciality Hospital), Sandra Luna‐Fineman(Children's Hospital Colorado), Stephen P. Hunger(Children's Hospital of Philadelphia), Guillermo Chantada(Hospital Sant Joan de Déu Barcelona), Trijn Israëls(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Alan Davidson(Red Cross War Memorial Children's Hospital), Francisco Pedrosa(St. Jude Children's Research Hospital), Raul C. Ribeiro(St. Jude Children's Research Hospital), Mhamed Harif(Institut d’Hématologie et d’Oncologie Pédiatrique), Simon Bailey(Newcastle University), Catherine G. Lam(St. Jude Children's Research Hospital)
Cited by 100
Related Papers
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|1.2k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
The Tumor Lysis Syndrome
|New England Journal of Medicine|2011|999